Treatment patterns of prostate cancer with bone metastasis in Beijing: A real-world study using data from an administrative claims database.
Yinchu ChengLin ZhuoYuting PanShengfeng WangJihong ZongWentao SunShuangqing GaoJian LuSiyan ZhanPublished in: Pharmacoepidemiology and drug safety (2019)
Our findings show that while a wide range of therapies are used to treat patients with prostate cancer and bone metastasis in Beijing, hormone therapy and bisphosphonate therapy are the most commonly prescribed, and use of CAB was seen to be advantageous in delaying time to chemotherapy initiation over NSAA monotherapy. Future studies should explore longer-term treatment patterns, including use of newly approved treatments.
Keyphrases
- prostate cancer
- radical prostatectomy
- bone mineral density
- air pollution
- combination therapy
- particulate matter
- stem cells
- preterm infants
- squamous cell carcinoma
- randomized controlled trial
- open label
- electronic health record
- postmenopausal women
- soft tissue
- bone loss
- big data
- study protocol
- bone regeneration
- locally advanced
- gestational age
- smoking cessation